Scientific Program

08:30-10:00Session 1: The oocyte I
Chairs: Milton Leong, Hong Kong & Zeev Shoham, Israel
Zeev Shoham, Israel, Milton Leong, Hong Kong
08:30-09:00Oocyte quality: Dysmorphic patterns and cytoskeletal alterations in human oocytes
Giovanni Coticchio, Italy
09:00-09:30Making human oocytes from stem cells
Evelyn Telfer, UK
09:30-10:00Identification of maturation-specific proteins in human oocytes by single-cell proteomics
Irma Virant-Klun, Slovenia
10:00-10:30Coffee Break & Poster Viewing
10:30-11:30Session 2: AMH for what?
Chairs: David Albertini, USA & Norbert Gleicher, USA
10:30-11:00New bio markers of ovarian reserve: AMH or nucleic acids - what is the best?
Samir Hamamah, France
11:00-11:30Administration of Anti-Mullerian Hormone (AMH) to prevent loss of ovarian reserve and protect fertility in chemotherapy treated mice
Dror Meirow, Israel
11:30-13:00Session 3: Special lectures: New developments
Chairs: David Albertini, USA & Norbert Gleicher, USA
11:30-12:00ART’S brave new world: The cat’s out of the bag… Newest unexpected discoveries in fundamental molecular, cell and reproductive biology
Gerald Schatten, USA
12:00-12:30Recent advances in endometrial receptivity diagnosis
Xavier Santamaria Costa, Spain
12:30-12:45In vitro formation of follicle-like structures from aggregations of human ovarian cells sorted using the external epitope of DDX4
Marie McLaughlin*; Yvonne Clarkson; Lori McPartlin; Yvonne White; Richard Anderson; Evelyn Telfer, UK
12:45-13:00Co-transplantation of human ovarian tissue with IGF-1 producing endothelial cells improves survival of early stage follicles and is associated with accelerated follicular growth in vivo
Limor Man*; Jovana Lekovich; Laura Park; Richard Bodine; Nikica Zaninovic; Zev Rosenwaks; Glenn Schattman; James Daylon, USA
13:00-13:45Lunch Break & Poster Viewing
13:45-15:15Session 4: Ovarian reserve and aging
Chairs: Kenneth S. Korach, USA & Herman Tournaye, Belgium
13:45-14:15Can we stop ovarian ageing?
Helen Picton, UK
14:15-14:45Establishment of the ovarian reserve: New insights from basic science and their clinical implications
Humphrey Yao, USA
14:45-15:15Revisiting the ovarian stroma: More than a holding zone for the follicle
David Albertini, USA
15:15-15:45Coffee Break & Poster Viewing
15:45-17:45Session 5: Egg & embryo health
Chairs: Helen Picton, UK & Ariel Weissman, Israel
15:45-16:15How small differences in dissolved oxygen in follicular fluid influence the developmental competence of the mature human oocyte at the molecular and plasmalemmal levels: Lessons from IVM, IVF and ICSI
Jonathan Van Blerkom, USA
16:15-16:45Nothing more controversial than PGS
Norbert Gleicher, USA
16:45-17:15Differences in chromosome abnormalities in eggs and embryos between fertility centers
Santiago Munne, USA
17:15-17:45Maximizing successful implantation: TLI, PGS and AnxaV M2 haplotype
Simon Fishel, UK
 17:45Welcome Reception

08:30-10:25Session 6: Implantation
Chairs: Pedro Barri, Spain & Anna Veiga, Spain
08:30-08:55How to make the best use of the natural cycle for frozen-thawed embryo transfer
Ariel Weissman, Israel
08:55-09:20Direct correlation between the serum Beta hCG level prior to egg retrieval and blastocyst formation. How come we have all missed it?
Matan Yemini, USA
09:20-09:45Searching for the optimal vehicle and dose of progesterone to support the luteal phase in ART
Herman Tournaye, Belgium
09:45-10:10Mini hCG for luteal phase support - a more physiologic LPS for ART treatment
Robert Fischer, Germany
10:10-10:25The relationship between blastocyst inner cell mass size and pregnancy outcome
Sheila Fieldust, Israel
10:25-11:00Coffee Break
11:00-12:00Session 7: Embryonic health
Chairs: Robert Fischer, Germany & Evelyn Telfer, UK
11:00-11:30In vitro culture in the presence of amorphous calcium carbonate improves mouse embryo compaction and hatching rates
Amir Arav, Israel
11:30-12:00Epigenetics effects from exposure toxicity of embryo’s
Kenneth S. Korach, USA
12:00-13:00Session 8: Rejuvenating the oocyte
Chair: Helen Picton, UK
12:00-12:30Mitochondria replacement strategies – When is it justified, and when NOT
Peter Braude, UK
12:30-13:00The strict regulation of the mitochondrial genome during development
Justin St. John, Australia
13:00-14:00Lunch Break
14:00-16:00Session 9: Stimulation and ovulation
Chairs: David Albertini, USA & Neeta Singh, India
14:00-14:30Ovarian stimulation and inflammation, not always friends!
Marc-André Sirard, Canada
14:30-15:00Adjuvant rLH to rFSH therapy in GnRH analogue cycles: What do recent meta-analyses add to current understanding?
Johnny S. Younis, Israel
15:00-15:30The place for surgical treatment for PCOS
Gab Kovacs, Australia
15:30-16:00The prostaglandin transporter (PGT): A novel indispensable mediator of ovulation - from basic research to clinical implications
Ariel Hourvitz, Israel
16:00-16:15Coffee Break
16:15-18:00Session 10: IVM: Innovations in this field
Chairs: Gerald Schatten, USA & Zeev Shoham, Israel
16:15-16:45In vitro systems to support complete development of immature oocytes
Evelyn Telfer, UK
16:45-17:15Protein source in embryo culture media affects DNA methylation and gene expression at the blastocyst
Pilar Coy, Spain
17:15Closing remarks

Please Note!

Any educational grants provided by our supporters are unrestricted.